Publication

Article

Generic Supplements
Volume 0
0

CE Exam

Articles in this issue
CE Exam
Clinical Perspectives in Erectile Dysfunction: Case Studies
PDE5s Revolutionize the Awareness and Treatment of Erectile Dysfunction
Emerging Treatments for the Management of Erectile Dysfunction
The Prevalence of Erectile Dysfunction and Associated Factors Among Men Worldwide
Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
Related Content
Fatigued mature old man taking off glasses suffering from tired dry irritated eyes after long computer use, senior middle aged male feels eye strain problem or blurry vision working on laptop at home - Image credit: fizkes | stock.adobe.com
October 21st 2024

Advise Patients About Routine Ophthalmic Health

Yvette C. Terrie, BSPharm, RPh
Health care professional and patient -- Image credit: thatinchan | stock.adobe.comHealth care professional and patient -- Image credit: thatinchan | stock.adobe.com
October 21st 2024

Review of 3 Alternative Pathways to Access Non–FDA-Approved Drugs

Emily Hennes, PharmD, BCOP Berrie Child, PharmD, BCOP Stefanie Conley, PharmD, BCOP Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB Sarah Lentz, BCOP Camille Smith, PharmD, DPLA, CCRP Jennifer Murphy, PharmD, BCOP
Acute lymphocytic leukemia -- Image credit: jarun011 | stock.adobe.com
October 18th 2024

Inotuzumab Ozogamicin in Pediatric Patients With Relapsed or Refractory B-Cell ALL

Basmah Zahid, PharmD, MS
October 2024 Product News
October 18th 2024

October 2024 Product News

PT Staff
Sarcoma -- Image credit: Saiful52 | stock.adobe.com
October 17th 2024

Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma

Hunter Sowell, PharmD Colleen McCabe, PharmD, BCOP Manuel Cortez, PharmD, BCOP Rachel Gilmore, PharmD Elizabeth Davis, MD Vicki Keedy, MD
Semaglutide injecting pen on a white background, macro. Needle macro - Image credit: artmim | stock.adobe.com
October 17th 2024

Concerns Linger About GLP-1 Inhibitors Despite Their Popularity

Jeannette Y. Wick, RPh, MBA, FASCP